Company Filing History:
Years Active: 2006-2008
Title: Michael C Hanna: Innovator in GABA Receptor Research
Introduction
Michael C Hanna is a notable inventor based in Arlington, VA (US). He has made significant contributions to the field of neuroscience through his innovative research on GABA receptors. With a total of 2 patents, his work focuses on the development of novel therapeutic methods.
Latest Patents
Hanna's latest patents revolve around the GABA receptor epsilon subunit (GABRE) and its alternative transcript, ET2. The inventions provide isolated nucleic acid molecules encoding human GABRE and ET2 receptor subunits. Additionally, the patents include GABRE and ET2 polypeptides, vectors, host cells, and recombinant methods for their production. The inventions also encompass screening methods for identifying agonists and antagonists of ET2 and GABRE activities. Furthermore, diagnostic methods for detecting aberrant GABRE and ET2 expression, as well as therapeutic methods for treating disorders involving these receptors, are included.
Career Highlights
Michael C Hanna is associated with Human Genome Sciences, Inc., where he continues to advance his research. His work has been instrumental in understanding the complexities of GABA receptor functions and their implications in various disorders.
Collaborations
Hanna collaborates with Ewen F Kirkness, contributing to the innovative research environment at Human Genome Sciences, Inc. Their combined expertise enhances the potential for groundbreaking discoveries in the field.
Conclusion
Michael C Hanna's contributions to GABA receptor research exemplify the impact of innovation in neuroscience. His patents and ongoing work continue to pave the way for new therapeutic approaches.